80 results
Page 3 of 4
8-K
EX-99.1
y3xapyjh
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
3xa1 fazhy9e
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
czrudzv
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
5ty2au n06nb8
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
fjpiwr
28 Jun 19
Regulation FD Disclosure
9:01am
8-K
EX-99.1
3bc0hycvjciypts br
27 Feb 19
Fibrogen Reports Fourth Quarter and Full Year 2018 Financial Results
12:00am
8-K
EX-99.1
7k197rv79rnplpvyfff
8 Nov 18
FIBROGEN REPORTS third QUARTER 2018 FINANCIAL RESULTS
4:05pm
8-K
luo6cv2u
30 Oct 18
Other Events
8:01am
8-K
EX-99.1
bevyozmyl
30 Oct 18
Other Events
8:01am
8-K
EX-99.1
jwhvd6ytjogl7p9xzv
26 Oct 18
Other Events
12:00am
8-K
43mirx5gu
26 Oct 18
Other Events
12:00am
8-K
EX-99.1
63zizybdmdm8 xl6
7 Aug 18
Fibrogen Reports Second Quarter 2018 Financial Results
12:00am
8-K
EX-99.1
4t00tjdf53ktt
8 Jun 18
Regulation FD Disclosure
5:27pm
8-K
nslossv8179u
21 May 18
Fibrogen Presents Latest Data from Praise Phase 2B Study of
5:04pm